dengu
common
arthropodborn
infect
worldwid
affect
least
million
peopl
everi
year
endem
countri
dengu
viru
singlestrand
rna
viru
four
major
serotyp
infect
one
serotyp
confer
homotyp
immun
heterolog
immun
secondari
infect
anoth
serotyp
may
lead
sever
diseas
major
rout
transmiss
occur
aed
aegypti
mosquito
vector
dengu
also
transmit
blood
transfus
organ
transplant
infect
result
spectrum
clinic
ill
rang
asymptomat
infect
undifferenti
fever
dengu
fever
dengu
haemorrhag
fever
dhf
dengu
shock
syndrom
dss
dengu
spread
rapidli
new
area
increas
frequenc
major
outbreak
trend
also
observ
toward
author
contribut
equal
work
increas
age
among
infect
patient
impact
blood
suppli
avail
blood
donor
defer
dengu
infect
exposur
infect
risk
transmiss
transfus
blood
asymptomat
viraem
donor
also
increas
although
screen
test
dengu
effect
pathogen
reduct
process
avail
blood
suppli
valu
implement
costli
measur
need
care
consid
demand
platelet
fresh
frozen
plasma
rise
increas
number
dhfdss
evidencebas
guidelin
clinic
use
blood
compon
manag
patient
dhfdss
well
establish
inappropri
use
contribut
challeng
face
blood
servic
key
word
blood
suppli
dengu
fever
dengu
viru
world
health
organ
classifi
dengu
major
intern
public
health
concern
billion
peopl
twofifth
popul
risk
infect
dengu
haemorrhag
fever
dhf
endem
countri
africa
america
eastern
mediterranean
southeast
asia
western
pacif
region
world
health
organ
worldwid
estim
million
dengu
infect
occur
everi
year
requir
hospit
affect
may
die
world
health
organ
figur
like
underestim
number
report
influenc
differ
surveil
report
system
well
vari
interpret
case
definit
presenc
miss
silent
infect
guhasapir
schimmer
prior
dengu
character
epidem
occur
rel
infrequ
gener
locat
involv
singl
viral
serotyp
suffici
number
vector
suscept
host
particular
serotyp
reach
sudden
sharp
rise
transmiss
occur
contrast
predomin
pattern
global
transmiss
today
hyperendem
dengu
continu
circul
multipl
viral
serotyp
within
constant
pool
suscept
host
vector
first
known
epidem
dhf
asia
occur
manila
philippin
follow
bangkok
thailand
malaysia
singapor
vietnam
econom
boom
associ
urban
rapidli
spread
involv
asia
dengu
overtaken
malaria
becom
lead
caus
hospit
death
among
children
region
increas
spread
also
seen
suburban
rural
area
gubler
america
erad
aegypti
vector
control
yellow
fever
sporad
case
report
earli
larg
outbreak
occur
cuba
mark
start
epidem
spread
pacif
american
tropic
dengu
preval
tropic
africa
although
dhf
rare
occur
occasion
temper
region
north
africa
mediterranean
region
epidem
report
comoro
dengu
continu
expand
territori
contin
current
experi
dengu
transmiss
europ
antarctica
factor
contribut
dramat
expans
dengu
includ
popul
growth
urban
inadequ
water
manag
lack
effect
mosquito
control
conveni
global
travel
last
year
chang
weather
pattern
may
contribut
expans
habitat
rang
mosquito
vector
increas
epidem
activ
may
also
increas
rate
viral
genet
chang
emerg
strain
genotyp
greater
epidem
potenti
gubler
messer
et
al
dash
et
al
although
dhf
primarili
ill
children
surveil
studi
recent
year
sever
countri
report
increas
age
among
infect
patient
liu
et
al
gupta
et
al
khan
et
al
ooi
et
al
singapor
ascrib
lower
herd
immun
popul
result
reduc
dengu
studi
shown
aegypti
bite
adult
frequent
children
de
benedicti
et
al
togeth
could
explain
higher
incid
rate
among
young
adult
singapor
dengu
viru
singlestrand
rna
viru
belong
flavivirida
famili
viral
genom
approxim
kb
length
surround
icosahedr
nucleocapsid
cover
lipid
envelop
matur
virion
three
structur
core
membraneassoci
envelop
seven
nonstructur
protein
envelop
protein
involv
main
biolog
function
respons
bind
transport
host
cell
also
associ
induct
neutral
antibodi
develop
protect
immun
respons
host
nonstructur
protein
express
membraneassoci
secret
form
implic
pathogenesi
sever
diseas
gubler
four
serotyp
classifi
accord
immunolog
properti
infect
one
dengu
serotyp
confer
lifelong
immun
serotyp
transient
protect
infect
serotyp
four
serotyp
associ
outbreak
seen
predomin
serotyp
primari
infect
outbreak
savag
et
al
messer
et
al
gupta
et
al
ooi
et
al
recent
data
also
demonstr
variou
genotyp
within
serotyp
possess
vari
epidem
potenti
anderson
ricohess
primari
vector
dengu
viru
aegypti
mosquito
although
viru
may
transmit
aed
albopictu
aed
polynesiensi
well
infect
human
main
carrier
amplif
host
dengu
viru
femal
mosquito
acquir
viru
bite
infect
human
viraem
phase
becom
infect
extrins
incub
period
day
subsequ
mosquito
may
transmit
viru
everi
feed
length
extrins
incub
period
depend
ambient
temperatur
viru
involv
affect
replic
rate
viru
vector
aed
aegypti
highli
domest
mosquito
breed
artifici
contain
water
storag
tank
subterranean
pit
flowerpot
tray
ornament
contain
vector
known
prefer
rest
indoor
although
studi
shown
may
seek
oviposit
outdoor
peak
bite
activ
dawn
dusk
multipl
feed
behaviour
aegypti
prefer
human
host
believ
contribut
explos
spread
dengu
viru
even
presenc
low
aegypti
popul
scott
et
al
laboratori
diagnosi
dengu
perform
viral
isol
serolog
test
dengu
antigen
test
molecular
detect
viru
isol
dengu
perform
inocul
sampl
live
mice
live
mosquito
cell
cultur
success
detect
viru
may
affect
presenc
interf
antibodi
heatlabil
natur
viru
normal
use
confirmatori
test
impract
diagnosi
screen
larg
scale
denguespecif
immunoglobulin
igm
immunoglobulin
g
igg
enzymelink
immunosorb
dengu
threat
blood
suppli
assay
elisa
wide
use
diagnosi
rel
inexpens
good
sensit
quick
easi
perform
igm
detect
day
infect
peak
week
declin
undetect
level
month
igg
becom
elev
day
persist
detect
level
life
secondari
infect
igg
increas
rapidli
much
higher
level
within
day
infect
viru
share
antigen
epitop
flavivirus
presenc
crossreact
antibodi
may
interfer
serolog
diagnosi
world
health
organ
dengu
antigencaptur
elisa
use
detect
dengu
earli
diseas
test
sensit
demonstr
significantli
higher
primari
dengu
infect
secondari
dengu
infect
posit
predict
valu
neg
predict
valu
kumarasami
et
al
although
use
first
week
diseas
provid
evid
presenc
viru
effect
screen
blood
donor
establish
yet
like
test
dengu
rna
test
detect
viral
materi
typic
present
first
day
diseas
advantag
test
good
sensit
specif
abil
rapidli
detect
minut
quantiti
dengu
viru
materi
serum
disadvantag
rel
high
cost
expertis
need
particularli
proper
qualiti
control
avoid
fals
posit
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
either
univers
dengu
oligonucleotid
primer
pair
combin
four
serotypespecif
oligonucleotid
primer
wide
use
clinic
diagnosi
public
health
surveil
establish
detect
limit
plaqueform
unit
pfu
ml
pfu
ml
pfu
ml
correl
viru
isol
lai
et
al
groupspecif
onestep
pcr
use
univers
dengu
oligonucleotid
primer
pair
sybr
green
wide
use
popul
surveil
fast
costeffect
mass
screen
detect
limit
pfu
ml
shu
et
al
lai
et
al
prototyp
dengu
rna
transcriptionmedi
amplif
tma
assay
genprob
inc
san
diego
ca
usa
develop
use
largescal
screen
blood
donor
sampl
use
target
genom
sequenc
highli
conserv
across
four
serotyp
analyt
sensit
assay
establish
detect
copi
ml
detect
limit
copi
ml
detect
limit
compar
sensit
four
serotyp
specif
dengu
infect
produc
spectrum
clinic
ill
undifferenti
fever
dengu
fever
df
dhf
dengu
shock
syndrom
dss
infant
children
younger
year
patient
usual
either
asymptomat
mild
undifferenti
febril
ill
maculopapular
rash
df
character
sudden
onset
high
fever
sever
headach
especi
retroorbit
area
arthralgia
myalgia
nausea
vomit
rash
infant
younger
children
tend
present
undifferenti
febril
diseas
often
rash
acut
febril
ill
last
approxim
day
dhf
clinic
defin
high
fever
haemorrhag
manifest
thrombocytopenia
evid
plasma
leakag
tabl
four
grade
sever
follow
must
present
fever
histori
acut
fever
last
day
occasion
biphas
haemorrhag
tendenc
evidenc
least
one
follow
posit
tourniquet
test
petechia
ecchymos
purpura
bleed
mucosa
gastrointestin
tract
inject
site
locat
haematemesi
melaena
thrombocytopenia
cell
mm
less
evid
plasma
leakag
increas
vascular
permeabl
manifest
least
one
follow
rise
haematocrit
equal
greater
averag
age
sex
popul
drop
haematocrit
follow
volum
replac
treatment
equal
greater
baselin
sign
plasma
leakag
pleural
effus
ascit
hypoproteinaemia
case
definit
dss
four
criteria
dhf
must
present
plu
evid
circulatori
failur
manifest
rapid
weak
puls
narrow
puls
pressur
mmhg
kpa
manifest
hypotens
age
cold
clammi
skin
restless
world
health
organ
defin
tabl
grade
iii
iv
consid
dss
presenc
thrombocytopenia
concurr
haemoconcentr
differenti
grade
ii
dhf
df
world
health
organ
clinic
deterior
usual
occur
toward
end
febril
phase
patient
progress
phase
plasma
leakag
plasma
leakag
manifest
tachycardia
hypotens
pleural
effus
ascit
develop
bleed
gastrointestin
tract
epistaxi
may
occur
menorrhagia
femal
epigastr
discomfort
myalgia
vomit
diarrhoea
abdomin
pain
common
adult
tender
hepatomegali
observ
patient
splenomegali
shock
plasma
leakag
mark
thrombocytopenia
common
children
wherea
intern
haemorrhag
frequent
age
increas
hammond
et
al
dhf
declin
platelet
count
tend
preced
plasma
leakag
platelet
count
pack
cell
volum
often
use
monitor
impend
deterior
tai
et
al
haemoconcentr
may
difficult
ascertain
area
signific
proport
popul
carri
thalassaemia
genet
trait
high
degre
iron
defici
khan
et
al
dss
medic
emerg
associ
high
mortal
sever
plasma
leakag
result
prolong
shock
accompani
metabol
acidosi
turn
precipit
dissemin
intraven
coagul
dic
massiv
haemorrhag
encephalopathi
may
develop
former
requir
intens
blood
transfus
support
sever
dengu
infect
result
complic
liver
failur
dic
encephalopathi
myocard
acut
renal
failur
haemolyticuraem
syndrom
gener
rare
usual
seen
patient
dhf
grade
iii
iv
malavig
specif
drug
dengu
viru
manag
symptomat
support
df
typic
selflimit
diseas
mortal
rate
less
although
convalesc
phase
may
sometim
prolong
adult
success
manag
dhf
lie
proper
manag
fluid
balanc
earli
identif
plasma
leakag
phase
prompt
resuscit
shown
reduc
complic
improv
outcom
adequ
treat
mortal
rate
dhf
low
untreat
exceed
world
health
organ
primari
pathophysiolog
seen
dhf
acut
increas
vascular
permeabl
lead
leakag
plasma
extravascular
compart
result
haemoconcentr
decreas
blood
pressur
increas
vascular
permeabl
shown
result
endotheli
gap
peripher
vascular
bed
necrot
inflammatori
lesion
seen
suggest
chang
function
like
caus
shortact
mediat
princip
mechan
dengu
viru
infect
caus
dhf
still
clearli
elucid
believ
result
viral
host
factor
involv
activ
cell
product
cytokineschemokin
disturb
haemostat
system
result
releas
cytokin
mediat
system
effect
plasma
leakag
circulatori
insuffici
addit
evid
increas
apoptosi
endotheli
cell
dysfunct
gubler
guglani
kabra
sever
infect
observ
occur
secondari
infect
primari
infect
pancharoen
et
al
variou
theori
put
forward
explain
observ
includ
phenomenon
antibodydepend
enhanc
recent
theori
origin
antigen
sin
mongkolsapaya
et
al
earli
stage
infect
thrombocytopenia
occur
result
bone
marrow
hypocellular
result
direct
dengu
infect
haematopoiet
progenitor
cell
stromal
cell
nakao
et
al
fever
settl
bone
marrow
hypercellular
seen
increas
destruct
immunemedi
clearanc
platelet
becom
primari
mechan
thrombocytopenia
mitrakul
et
al
dengu
threat
blood
suppli
agerel
differ
suscept
dhfdss
although
children
infect
dengu
viru
tend
manifest
milder
clinic
symptom
adult
higher
risk
develop
dhfdss
hammond
et
al
ooi
et
al
postul
children
greater
propens
vascular
leakag
normal
physiolog
condit
adult
result
less
abil
accommod
addit
factor
increas
vascular
permeabl
hospit
death
rate
sever
sever
dengu
highest
younger
year
older
year
et
al
elderli
patient
older
year
like
develop
sever
ill
higher
risk
hospit
death
infect
dengu
viru
youth
younger
adult
age
year
histori
dengu
infect
diabet
mellitu
hypertens
renal
insuffici
identifi
significantli
associ
dhfdss
lee
et
al
genet
influenc
includ
human
leucocyt
antigen
allel
associ
may
play
part
diseas
suscept
sever
wagenaar
et
al
haiti
dhf
case
record
despit
transmiss
rate
evid
show
presenc
four
serotyp
popul
halstead
et
al
similar
pauciti
dhf
case
africa
despit
presenc
dengu
viru
popul
suggest
presenc
dengu
resist
gene
primari
mode
transmiss
dengu
viru
occur
mosquito
vector
bite
infect
mosquito
dengu
viru
enter
bodi
replic
within
cell
mononuclear
phagocyt
lineag
usual
incub
period
day
averag
day
period
viraemia
roughli
correspond
period
fever
peak
time
shortli
onset
ill
remain
detect
variou
period
typic
day
correl
durat
viraemia
serotyp
studi
report
correl
viraemia
diseas
sever
wherea
other
report
correl
gubler
et
al
vaughn
et
al
murgu
et
al
infect
incub
period
well
defin
partli
lack
anim
model
dengu
studi
involv
human
volunt
clinic
appar
df
result
bite
experi
day
onset
fever
indic
infect
person
could
transmit
viru
earli
even
earlier
day
symptom
develop
nishiura
halstead
vertic
transmiss
report
intrapartum
transmiss
least
two
case
onset
neonat
ill
develop
first
day
life
sirinavin
et
al
one
case
involv
mother
diagnos
dhf
prior
deliveri
et
al
nosocomi
transmiss
needlestick
injuri
mucocutan
exposur
also
report
case
mucocutan
transmiss
involv
healthcar
worker
develop
dengu
infect
blood
febriledengueinfect
travel
splash
onto
face
chen
wilson
transmiss
dengu
infect
report
donor
recipi
one
case
live
donor
renal
transplant
tan
et
al
clinic
present
cours
ill
similar
immunocompet
patient
except
prolong
cours
ill
day
durat
thrombocytopenia
day
transmiss
bone
marrow
transplant
report
one
instanc
dengu
epidem
puerto
rico
et
al
bone
marrow
recipi
develop
fever
day
transplant
subsequ
die
donor
develop
fever
headach
day
marrow
harvest
two
report
instanc
transmiss
blood
transfus
first
involv
patient
hong
kong
develop
fever
day
blood
transfus
associ
moder
neutropenia
sever
thrombocytopenia
hypotens
respons
fluid
therapi
donor
asymptomat
time
donat
develop
mild
symptom
df
day
blood
donat
archiv
sampl
donat
also
test
posit
dengu
viru
rtpcr
chuang
et
al
c
k
lin
hong
kong
red
cross
blood
transfus
servic
hong
kong
per
comm
second
involv
transmiss
dengu
asymptomat
blood
donor
develop
acut
febril
ill
day
donat
blood
look
back
investig
confirm
dengu
infect
recipi
three
blood
product
donat
two
recipi
df
evid
capillari
leakag
wherea
platelet
recipi
asymptomat
seroconvers
recov
without
sequela
store
serum
sampl
donat
test
posit
rtpcr
tambyah
et
al
small
number
report
transfus
transmiss
could
fact
difficult
differenti
nonmosquito
transmiss
mosquitoborn
infect
endem
area
vector
widespread
mani
infect
may
also
result
mild
asymptomat
ill
recogn
transfusionacquir
infect
diagnost
laboratori
document
infect
sourc
often
avail
mani
endem
countri
chen
wilson
variou
studi
shown
presenc
asymptomat
subclin
infect
rang
depend
popul
studi
estim
everi
one
symptomat
case
case
asymptomat
chen
wilson
correl
total
dengu
incid
hospit
rate
age
sex
although
one
studi
found
silent
transmiss
occur
commonli
age
group
studi
healthi
volunt
provinc
thailand
high
rate
dengu
infect
serum
sampl
posit
dengu
igm
two
sampl
test
posit
viral
rna
poblap
et
al
cluster
sampl
studi
around
index
case
indonesia
detect
eight
postenrol
asymptomat
dengu
infect
volunt
period
two
demonstr
viraemia
rtpcr
beckett
et
al
viru
isol
person
studi
evalu
dynam
transmiss
dengu
viru
dengu
epidem
area
colombia
asymptomat
et
al
two
recent
studi
report
viraemia
blood
donat
collect
four
countri
experienc
high
dengu
transmiss
rate
first
studi
blood
donat
collect
puerto
rico
test
posit
use
denguespecif
tma
nucleic
acid
amplif
test
nat
moham
et
al
supplement
test
use
rtpcr
posit
four
sampl
viral
load
copi
ml
live
viru
recov
three
pcrposit
sampl
second
studi
sampl
asymptomat
blood
donor
hondura
brazil
australia
obtain
period
clinic
dengu
outbreak
screen
use
denguespecif
tma
assay
nine
honduran
sampl
test
posit
confirm
rtpcr
viral
load
copi
ml
sampl
yield
infecti
virus
three
brazilian
sampl
test
posit
rtpcr
posit
viral
load
copi
ml
viral
isol
perform
sampl
dengu
spread
rapidli
new
area
major
outbreak
occur
greater
frequenc
half
world
endem
dengu
increas
likelihood
blood
donor
countri
infect
expos
infect
number
continu
increas
effect
blood
donor
attend
reach
level
suffici
enough
impact
significantli
blood
suppli
countri
donor
infect
dengu
viru
defer
period
month
tabl
even
longer
receiv
blood
transfus
blood
donor
donat
regularli
particularli
affect
includ
apheresi
donor
may
donat
often
time
year
healthi
uninfect
donor
whose
famili
member
work
colleagu
infect
dengu
also
like
defer
donat
blood
donor
would
also
less
time
avail
donat
blood
would
need
care
sick
famili
member
take
increas
work
respons
result
workplac
ill
past
dengu
affect
mainli
children
donat
blood
trend
revers
modal
age
infect
increas
dengu
increasingli
affect
segment
popul
donat
blood
youth
young
adult
reduc
blood
donor
avail
annual
incid
dengu
infect
singapor
per
popul
highest
incid
segment
popul
older
year
estim
dengu
infect
reduc
blood
donor
pool
exclud
donor
defer
symptom
relat
dengu
exposur
dengu
estim
lose
donor
increas
preval
popul
increas
risk
blood
collect
viraem
donor
asymptomat
subclin
phase
infect
transmiss
dengu
blood
collect
asymptomat
donor
demonstr
two
report
hong
kong
singapor
occur
height
epidem
countri
chuang
et
al
tambyah
et
al
blood
servic
countri
experienc
dengu
epidem
need
decid
whether
stronger
measur
need
protect
blood
suppli
infecti
diseas
outbreak
dengu
sever
acut
respiratori
syndrom
sar
chikungunya
diseas
countri
adopt
risk
reduct
strategi
focu
exclud
donor
may
higher
risk
infect
may
exhibit
earli
symptom
infect
case
dengu
reli
mainli
question
donor
recent
histori
travel
outbreak
area
symptom
fever
rash
malais
rel
low
sensit
specif
blood
safeti
measur
base
donor
histori
long
debat
travelrel
deferr
particular
lead
high
rate
unnecessari
donor
deferr
addit
often
neg
effect
donor
defer
mani
donor
return
even
deferr
temporari
halperin
et
al
introduc
measur
outbreak
dengu
like
exacerb
problem
dwindl
donor
attend
decreas
blood
collect
describ
earlier
exampl
singapor
sar
outbreak
chikungunya
outbreak
result
donor
deferr
rate
respect
popul
dengu
endem
exclus
basi
symptom
also
fail
address
risk
collect
blood
asymptomat
viraem
donor
studi
far
suggest
least
day
period
infect
prior
develop
symptom
presenc
dengu
viraemia
asymptomat
person
includ
blood
donor
well
document
dengu
epidem
effici
transmiss
depend
combin
factor
amount
stabil
viru
volum
viraem
blood
transfus
immun
statu
recipi
although
dengu
viraemia
titr
vertebr
host
usual
rang
copi
ml
chen
wilson
like
lower
level
shorter
durat
viraemia
occur
asymptomat
infect
compar
df
dhf
moham
et
al
linnen
et
al
demonstr
presenc
viral
load
least
copi
ml
copi
ml
respect
healthi
blood
donor
experi
west
nile
viru
wnv
suggest
posit
donat
infecti
two
studi
live
viru
recov
posit
donat
indic
donat
capabl
transmit
infect
recipi
viral
load
present
order
copi
ml
copi
ml
contrast
cell
cultur
neg
five
donat
viral
load
copi
ml
although
suggest
lower
viral
load
associ
lower
risk
infect
wnv
transmit
transfus
estim
viral
load
low
pfu
ml
copi
ml
therefor
possibl
larger
volum
involv
blood
transfus
could
still
transmit
infect
despit
lower
viral
load
concentr
risk
infect
also
depend
size
popul
expos
infect
immun
prior
infect
infect
may
occur
major
individu
previous
infect
develop
protect
antibodi
studi
prototyp
dengu
nat
system
show
suffici
sensit
earli
detect
enabl
interdict
infect
donat
howev
like
individu
sampl
nat
rather
minipool
nat
requir
dengu
screen
rel
low
level
dengu
rna
moham
et
al
time
write
least
two
dengu
nat
system
blood
suppli
screen
develop
genprob
ltd
roch
diagnost
ltd
possibl
commerci
avail
within
next
year
cost
system
avail
yet
unlik
less
current
wnvnat
hepat
b
viru
nat
hbvnat
altern
strategi
test
pathogen
reduct
ad
advantag
effect
infect
transmit
blood
chikungunya
viru
wnv
preliminari
studi
use
amotosalenhcl
longwavelength
ultraviolet
light
uva
system
apheresi
platelet
shown
effect
dengu
viru
lam
et
al
pathogen
reduct
technolog
yet
avail
red
cell
somewhat
limit
impact
nonetheless
vectortransmit
infect
emerg
threaten
blood
suppli
pathogen
reduct
platelet
plasma
coupl
select
red
cell
inventori
hold
may
use
reduc
transmiss
risk
without
unnecessari
donor
deferr
regardless
whether
new
screen
assay
pathogen
reduct
method
select
recent
experi
human
immunodefici
viru
nat
hivnat
hepat
c
viru
nat
hcvnat
suggest
involv
high
cost
expens
technic
expertis
marshal
et
al
littl
doubt
transfusiontransmit
infect
repres
small
fraction
total
infect
epidem
countri
high
dengu
preval
introduct
screen
test
pathogen
reduct
process
therefor
like
prevent
infect
blood
transfus
proport
would
low
comparison
total
number
infect
tabl
dengu
carri
high
econom
burden
societi
term
medic
cost
control
measur
well
increas
costeffect
depend
abil
reduc
risk
transfusiontransmit
diseas
well
reduc
workforc
product
gubler
guhasapir
schimmer
develop
countri
limit
resourc
decis
implement
costli
risk
reduct
strategi
blood
suppli
must
take
consider
costeffect
reduc
diseas
morbid
relat
overal
health
situat
countri
costeffect
risk
reduct
strategi
transfusiontransmit
diseas
depend
clinic
consequ
recipi
health
whether
infect
acquir
blood
transfus
result
seriou
diseas
studi
report
clinic
effect
superimpos
dengu
infect
patient
retrospect
analysi
brazil
primari
dengu
infect
renal
transplant
recipi
show
similar
clinic
pictur
outcom
gener
popul
azevedo
et
al
report
french
guiana
pregnant
women
df
pregnanc
found
abnorm
infant
observ
higher
foetal
death
rate
usual
suggest
dengu
infect
might
increas
risk
foetal
mortal
carl
et
al
superimpos
dengu
may
subject
patient
addit
risk
tan
et
al
note
case
report
occurr
dhf
earli
postop
pose
potenti
danger
transplant
patient
result
persist
haemorrhag
cut
tissu
surfac
associ
bleed
diathesi
recipi
blood
transfus
older
age
group
therefor
increas
risk
dhf
complic
follow
dengu
infect
higher
risk
patient
involv
secondari
infect
differ
serotyp
also
studi
case
studi
suggest
dengu
acquir
blood
transfus
result
sever
ill
acquir
usual
vector
rout
transmiss
four
patient
acquir
infect
blood
transfus
hong
kong
singapor
experienc
rel
benign
cours
ill
unev
recoveri
seriou
sequela
could
lower
viral
load
present
blood
donat
collect
nevertheless
data
need
make
firm
conclus
blood
transfus
indic
case
signific
clinic
bleed
exact
platelet
count
platelet
transfus
given
dengu
infect
still
well
defin
although
clinic
guidelin
recommend
platelet
transfus
given
patient
develop
seriou
haemorrhag
manifest
low
platelet
count
platelet
count
fall
l
without
haemorrhag
l
bleed
haemorrhag
children
littl
correl
platelet
count
bleed
manifest
platelet
count
diseas
sever
malavig
studi
risk
factor
haemorrhag
paediatr
patient
dss
show
correl
bleed
platelet
count
prolong
durat
shock
fact
strongest
risk
factor
haemorrhag
lum
et
al
adult
platelet
count
l
pack
cell
volum
significantli
associ
presenc
bleed
manifest
malavig
howev
uncompl
dengu
patient
one
studi
patient
found
differ
morbid
platelet
count
l
without
fever
lye
et
al
anoth
studi
dengu
patient
show
correl
clinic
bleed
platelet
count
nonbleed
patient
count
less
l
chaudhari
et
al
contrast
anoth
studi
dengu
patient
suggest
bleed
occur
often
patient
platelet
count
l
makroo
et
al
studi
paediatr
patient
dss
thrombocytopenia
coagulopathi
signific
differ
haemorrhag
patient
receiv
prevent
transfus
compar
patient
receiv
transfus
higher
frequenc
develop
pulmonari
oedema
increas
length
hospit
lum
et
al
corticosteroid
shown
effect
placebo
treatment
reduc
number
death
need
blood
transfus
number
seriou
complic
panpanich
et
al
random
control
studi
two
treatment
group
treat
without
intraven
immunoglobulin
also
show
effect
hasten
recoveri
platelet
count
patient
secondari
dengu
infect
dimaano
et
al
contrast
interim
data
two
random
placebocontrol
trial
patient
dhf
thrombocytopenia
shown
increas
platelet
count
antid
immun
globulin
de
castro
et
al
use
recombin
activ
factor
vii
rfviia
may
also
use
dhf
massiv
bleed
effect
respons
report
thai
children
grade
iii
iv
dhf
lifethreaten
bleed
treat
rfviia
chuansumrit
et
al
explos
outbreak
dhf
often
associ
increas
need
blood
compon
especi
platelet
platelet
transfus
base
commonli
accept
consensu
guidelin
patient
df
dhf
requir
platelet
transfus
lye
et
al
larg
epidem
translat
signific
increas
platelet
requir
height
dengu
epidem
singapor
signific
increas
platelet
transfus
record
fig
due
increas
requir
dhf
patient
inappropri
order
use
platelet
aggrav
increas
requir
addit
expos
patient
unnecessari
transfus
risk
chaudhari
et
al
report
studi
patient
receiv
unnecessari
prophylact
transfus
inappropri
dose
given
transfus
episod
df
epidem
anoth
studi
patient
still
receiv
inappropri
transfus
despit
presenc
platelet
transfus
guidelin
makroo
et
al
area
blood
servic
less
well
develop
lack
transfus
specialist
lack
knowledg
becom
major
factor
lead
inappropri
use
blood
blood
product
lum
et
al
recommend
prevent
haemorrhag
patient
dhf
better
achiev
earli
detect
manag
circulatori
imbal
shock
transfus
develop
clear
specif
guidelin
platelet
fresh
frozen
plasma
transfus
dengu
may
use
reduc
unnecessari
use
blood
compon
particularli
area
limit
resourc
wider
access
medic
care
health
provid
knowledg
dhf
reduc
death
rate
less
world
health
organ
unfortun
mani
develop
countri
rural
area
lack
access
blood
suppli
facil
often
basic
poorli
resourc
dengu
spread
rural
area
challeng
provid
suffici
suppli
safe
blood
blood
compon
treat
dhfdssassoci
medic
emerg
place
heavi
demand
blood
servic
countri
